Tag: Sentante
Sentante lands CE-mark approval for endovascular robotic platform
Sentante has announced it has secured CE-mark approval for its flagship device—a multi-domain robotic platform technology—marking a “major transition” from research and development to...
Sentante’s robotic stroke system accepted into US FDA total product life...
Sentante has announced that its robotic system has been accepted into the US Food and Drug Administration’s (FDA) total product life cycle advisory programme...
Sentante conducts first remote stroke thrombectomy procedures in living subjects
Medical robotics company Sentante has conducted its first study involving live subjects, with surgeons using its unique haptic endovascular platform on animal models from...
Sentante announces successful completion of transatlantic remote stroke intervention
Sentante announced in a recent press release that it has successfully achieved a “first-of-a-kind” remote stroke procedure—performed by specialist surgeons guiding the interventions from...
Sentante stroke system receives US FDA Breakthrough Device designation
Sentante recently shared that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for the company's robotic stroke system.
A press release...
